Please log in to get access to this content
A discussion of the HEART-FID trial of ferric carboxymaltose in patients with heart failure and iron deficiency, and a meta-analysis of pooled individual participant data from 4,501 adult patients with HF and iron deficiency across three separate trials.
Speaker
- Prof. Dr. Michael Böhm
Saarland University Hospital, Homburg, Germany